Part 2 of our interview with Todd Harrison, co-chair of the FDA practice group at Venable LLP covers preclusion's structural gaps: no defined end point, no tracking registry, and a push for mandatory drug-sponsor engagement.

Todd Harrison, co-chair of the FDA practice group at Venable LLP, details the Dietary Supplement Innovation Act's language, its unintended consequences, and what industry stakeholders should watch for.

The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.

The company's "IVC Advantage" pairs market research with formulation and manufacturing scale for brands launching products.

A randomized, crossover trial found that ThymoDream, a standardized black cumin seed oil, raised endogenous melatonin levels and improved several sleep measures over 7 nights, with lower reported daytime sleepiness than synthetic melatonin.

Ahead of the Las Vegas trade show, BSCG outlines how its five certification programs address banned substances, label accuracy, GMP compliance, and CBD verification.

Research conducted on beauty and nutritional needs for women in Asia-Pacific outlines needs across four life stages and what they mean for supplement formulators.

Piping Rock Health Products has launched a 300-mg NMN gummy under its Vitafusion brand, arriving less than a year after the FDA reversed its position on whether the ingredient could legally be sold as a dietary supplement.